x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
20-5657551
|
|
(State
or other jurisdiction of incorporation of organization)
|
(I.R.S.
Employer Identification Number)
|
Page
|
||
PART
I.
|
FINANCIAL
INFORMATION
|
|
Item
1.
|
Financial
Statements (Unaudited)
|
|
Condensed
Consolidated Balance Sheets as of June 30, 2007
|
||
and
December 31, 2006
|
1
|
|
|
||
Condensed
Consolidated Statements of Income for the Three and Six-
|
||
Month
Periods Ended June 30, 2007 and 2006
|
2
|
|
|
||
Condensed
Consolidated Statements of Cash Flows for the Six-
|
||
Month
Periods Ended June 30, 2007 and 2006
|
3
|
|
|
||
Notes
to Condensed Consolidated Financial Statements
|
4
|
|
|
||
Item
2.
|
Management’s
Discussion and Analysis of
|
|
Financial
Condition and Results of Operations
|
11
|
|
|
||
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
13
|
|
||
Item
4.
|
Controls
and Procedures
|
13
|
|
||
PART
II.
|
OTHER
INFORMATION
|
|
|
||
Item
1.
|
Legal
Proceedings
|
14
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
14
|
Item
3.
|
Defaults
upon Senior Securities
|
14
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
14
|
Item
5.
|
Other
Information
|
15
|
Item
6.
|
Exhibits
|
15
|
|
||
SIGNATURES
|
16
|
June
30,
2007
|
December
31,
2006 |
||||||
(Unaudited)
|
(Note
B)
|
||||||
Assets
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
32,604
|
$
|
24,405
|
|||
Short-term
investments
|
-
|
8,000
|
|||||
Accounts
receivable, net of allowances for doubtful accounts of
$150
|
15,517
|
16,724
|
|||||
Inventories
|
210
|
203
|
|||||
Deferred
income taxes
|
4,866
|
4,972
|
|||||
Prepaid
expenses and other current assets
|
1,255
|
1,916
|
|||||
Total
current assets
|
54,452
|
56,220
|
|||||
Equipment,
net of accumulated depreciation of $9,977 and $8,845,
respectively
|
4,928
|
4,051
|
|||||
Goodwill
|
2,119
|
2,119
|
|||||
Other
intangible assets, net of accumulated amortization of $1,261 and
$1,205,
respectively
|
1,106
|
1,156
|
|||||
Deferred
income taxes
|
1,858
|
885
|
|||||
Other
assets
|
1,892
|
1,229
|
|||||
Total
assets
|
$
|
66,355
|
$
|
65,660
|
|||
Liabilities
and Shareholders’ Equity
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable
|
$
|
7,203
|
$
|
7,632
|
|||
Accrued
liabilities
|
3,283
|
9,873
|
|||||
Total
current liabilities
|
10,486
|
17,505
|
|||||
Other
liabilities
|
1,263
|
500
|
|||||
Total
liabilities
|
11,749
|
18,005
|
|||||
Shareholders'
equity:
|
|||||||
Common
stock, $.01 par value, 40,000,000 shares authorized, 22,298,647 and
22,086,728 shares issued, respectively
|
223
|
221
|
|||||
Additional
paid-in capital
|
109,068
|
103,122
|
|||||
Accumulated
deficit
|
(55,051
|
)
|
(56,044
|
)
|
|||
Accumulated
other comprehensive income
|
94
|
79
|
|||||
Nil
coupon perpetual loan notes
|
272
|
277
|
|||||
Total
shareholders' equity
|
54,606
|
47,655
|
|||||
Total
liabilities and shareholders' equity
|
$
|
66,355
|
$
|
65,660
|
Three
Months Ended
June
30
|
Six
Months Ended
June
30
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
sales
|
$
|
16,210
|
$
|
19,759
|
$
|
32,472
|
$
|
36,880
|
|||||
Costs
and expenses:
|
|||||||||||||
Cost
of sales
|
9,083
|
10,112
|
18,040
|
19,168
|
|||||||||
Selling,
general and administrative
|
6,563
|
6,039
|
12,469
|
11,463
|
|||||||||
Research
and development
|
557
|
499
|
1,111
|
850
|
|||||||||
16,203
|
16,650
|
31,620
|
31,481
|
||||||||||
Operating
income
|
7
|
3,109
|
852
|
5,399
|
|||||||||
Interest
income
|
419
|
247
|
836
|
397
|
|||||||||
Other
expense
|
(30
|
)
|
(1
|
)
|
(71
|
)
|
(19
|
)
|
|||||
Income
before taxes
|
396
|
3,355
|
1,617
|
5,777
|
|||||||||
Income
tax expense
|
(114
|
)
|
(1,397
|
)
|
(543
|
)
|
(2,469
|
)
|
|||||
Net
income
|
$
|
282
|
$
|
1,958
|
$
|
1,074
|
$
|
3,308
|
|||||
Net
income per Common Share:
|
|||||||||||||
Basic
|
$
|
0.01
|
$
|
0.09
|
$
|
0.05
|
$
|
0.16
|
|||||
Diluted
|
$
|
0.01
|
$
|
0.08
|
$
|
0.04
|
$
|
0.14
|
|||||
Weighted-average
number of Common Shares outstanding:
|
|||||||||||||
Basic
|
22,220,000
|
21,697,000
|
22,164,000
|
21,158,000
|
|||||||||
Diluted
|
24,679,000
|
24,230,000
|
24,666,000
|
24,004,000
|
Six
Months Ended
June
30
|
|||||||
2007
|
2006
|
||||||
Operating
activities
|
|||||||
Net
cash used in operating activities
|
$
|
(1,062
|
)
|
$
|
(708
|
)
|
|
Investing
activities
|
|||||||
Sales
(purchases) of short-term investments
|
8,000
|
(10,200
|
)
|
||||
Purchases
of equipment and patents
|
(2,028
|
)
|
(1,333
|
)
|
|||
Net
cash provided by (used in) investing activities
|
5,972
|
(11,533
|
)
|
||||
Financing
activities
|
|||||||
Proceeds
from exercise of stock options
|
785
|
2,880
|
|||||
Issuance
of deferred shares of stock
|
1,110
|
-
|
|||||
Income
tax benefit from exercise of stock options
|
1,379
|
2,788
|
|||||
Net
cash provided by financing activities
|
3,274
|
5,668
|
|||||
Effect
of exchange rate fluctuations on cash
|
15
|
74
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
8,199
|
(6,499
|
)
|
||||
Cash
and cash equivalents at beginning of period
|
24,405
|
10,375
|
|||||
Cash
and cash equivalents at end of period
|
$
|
32,604
|
$
|
3,876
|
Three
Months Ended
June
30
|
Six
Months Ended
June
30
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Basic
weighted-average shares
|
22,220
|
21,697
|
22,164
|
21,158
|
|||||||||
Conversion
of unsecured loan notes
|
45
|
46
|
45
|
46
|
|||||||||
Unexercised
options and warrants
|
2,414
|
2,487
|
2,457
|
2,800
|
|||||||||
Diluted
weighted-average shares
|
24,679
|
24,230
|
24,666
|
24,004
|
in
thousands of U.S. dollars
|
Three
Months Ended
June
30
|
Six
Months Ended
June
30
|
|||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Comprehensive
income:
|
|||||||||||||
Net
income
|
$
|
282
|
$
|
1,958
|
$
|
1,074
|
$
|
3,308
|
|||||
Foreign
currency translation
|
12
|
51
|
15
|
74
|
|||||||||
$
|
294
|
$
|
2,009
|
$
|
1,089
|
$
|
3,382
|
2007
|
2006
|
||||||
Expected
dividend yield
|
0.00
|
%
|
0.00
|
%
|
|||
Risk-free
interest rate
|
4.78
|
%
|
4.90
|
%
|
|||
Expected
volatility
|
56.9
|
%
|
64.0
|
%
|
|||
Expected
life of option
|
5.1
years
|
5.3
years
|
Number
of
Options
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average Remaining Contractual Term
|
Aggregate
Intrinsic Value
|
||||||||||
Outstanding
on January 1, 2007
|
2,414,200
|
$
|
13.02
|
||||||||||
Granted
|
116,500
|
25.80
|
|||||||||||
Exercised
|
(163,250
|
)
|
4.81
|
$
|
3,823
|
||||||||
Expired
or forfeited
|
(55,000
|
)
|
19.09
|
||||||||||
Outstanding
on June 30, 2007
|
2,312,450
|
$
|
14.09
|
8.03
years
|
$
|
47,557
|
|||||||
Exercisable
on June 30, 2007
|
645,450
|
$
|
7.33
|
6.08
years
|
$
|
17,643
|
|||||||
Weighted-average
fair value of options granted during the six months ended June 30,
2007
|
$
|
14.05
|
Nonvested
Stock Outstanding
|
||||
Outstanding
on January 1, 2007
|
1,702,750
|
|||
Granted
|
116,500
|
|||
Released
|
(97,250
|
)
|
||
Expired
or forfeited
|
(55,000
|
)
|
||
Outstanding
on June 30, 2007
|
1,667,000
|
Three
months ended
June
30, 2007
|
Nitrogen
Oxide Reduction
|
Fuel
Treatment Chemical
|
Other
|
Total
|
|||||||||
Net
sales from external customers
|
$
|
7,648
|
$
|
8,562
|
$
|
-
|
$
|
16,210
|
|||||
Cost
of sales
|
4,745
|
4,304
|
34
|
9,083
|
|||||||||
Gross
margin
|
2,903
|
4,258
|
(34
|
)
|
7,127
|
||||||||
Selling,
general and administrative
|
-
|
-
|
6,563
|
6,563
|
|||||||||
Research
and development
|
-
|
-
|
557
|
557
|
|||||||||
Operating
income (loss)
|
$
|
2,903
|
$
|
4,258
|
$
|
(7,154
|
)
|
$
|
7
|
Three
months ended
June
30, 2006
|
Nitrogen
Oxide Reduction
|
Fuel
Treatment Chemical
|
Other
|
Total
|
|||||||||
Net
sales from external customers
|
$
|
13,155
|
$
|
6,604
|
$
|
-
|
$
|
19,759
|
|||||
Cost
of sales
|
7,260
|
2,810
|
42
|
10,112
|
|||||||||
Gross
margin
|
5,895
|
3,794
|
(42
|
)
|
9,647
|
||||||||
Selling,
general and administrative
|
-
|
-
|
6,039
|
6,039
|
|||||||||
Research
and development
|
-
|
-
|
499
|
499
|
|||||||||
Operating
income (loss)
|
$
|
5,895
|
$
|
3,794
|
$
|
(6,580
|
)
|
$
|
3,109
|
Six
months ended
June
30, 2007
|
Nitrogen
Oxide Reduction
|
Fuel
Treatment Chemical
|
Other
|
Total
|
|||||||||
Net
sales from external customers
|
$
|
16,257
|
$
|
16,215
|
$
|
-
|
$
|
32,472
|
|||||
Cost
of sales
|
9,772
|
8,199
|
69
|
18,040
|
|||||||||
Gross
margin
|
6,485
|
8,016
|
(69
|
)
|
14,432
|
||||||||
Selling,
general and administrative
|
-
|
-
|
12,469
|
12,469
|
|||||||||
Research
and development
|
-
|
-
|
1,111
|
1,111
|
|||||||||
Operating
income (loss)
|
$
|
6,485
|
$
|
8,016
|
$
|
(13,649
|
)
|
$
|
852
|
Six
months ended
June
30, 2006
|
Nitrogen
Oxide Reduction
|
Fuel
Treatment Chemical
|
Other
|
Total
|
|||||||||
Net
sales from external customers
|
$
|
25,520
|
$
|
11,360
|
$
|
-
|
$
|
36,880
|
|||||
Cost
of sales
|
14,148
|
4,928
|
92
|
19,168
|
|||||||||
Gross
margin
|
11,372
|
6,432
|
(92
|
)
|
17,712
|
||||||||
Selling,
general and administrative
|
-
|
-
|
11,463
|
11,463
|
|||||||||
Research
and development
|
-
|
-
|
850
|
850
|
|||||||||
Operating
income (loss)
|
$
|
11,372
|
$
|
6,432
|
$
|
(12,405
|
)
|
$
|
5,399
|
Three
months ended June 30
|
Six
months ended June 30
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
sales:
|
|||||||||||||
United
States
|
$
|
11,584
|
$
|
13,293
|
$
|
25,591
|
$
|
26,199
|
|||||
Foreign
|
4,626
|
6,466
|
6,881
|
10,681
|
|||||||||
$
|
16,210
|
$
|
19,759
|
$
|
32,472
|
$
|
36,880
|
|
June
30, 2007
|
December
31, 2006
|
|||||
Assets:
|
|||||||
United
States
|
$
|
62,498
|
$
|
62,190
|
|||
Foreign
|
3,857
|
3,470
|
|||||
$
|
66,355
|
$
|
65,660
|
Director
|
For
|
Withhold
|
|||||
Douglas
G. Bailey
|
17,805,858
|
1,267,756
|
|||||
Ralph
E. Bailey
|
18,563,071
|
510,543
|
|||||
Miguel
Espinosa
|
18,873,969
|
199,645
|
|||||
Charles
W. Grinnell
|
18,572,526
|
501,088
|
|||||
Thomas
L. Jones
|
18,870,474
|
203,140
|
|||||
Samer
S. Khanachet
|
18,869,732
|
203,882
|
|||||
John
D. Morrow
|
18,868,077
|
205,537
|
|||||
John
F. Norris Jr.
|
18,718,651
|
354,963
|
|||||
Thomas
S. Shaw, Jr.
|
18,107,466
|
966,148
|
For
|
Against
|
Abstain
|
|||||
18,071,886
|
28,839
|
972,889
|
For
|
Against
|
Abstain
|
|||||
12,458,332
|
286,604
|
1,019,403
|
Date: August 6, 2007 | By: | /s/ John F. Norris Jr. |
John
F. Norris Jr.
Director,
President and Chief Executive
Officer
|
Date: August 6, 2007 | By: | /s/ Vincent J. Arnone |
Vincent
J. Arnone
Chief
Financial Officer,
Sr.
Vice President and Treasurer
|